Osteopenia and Osteoporosis in Pediatric Patients After Stem Cell Transplant

Abstract

As more patients are surviving the transplant experience, more children are coping with long-term side effects. Long-term side effects, such as osteopenia and osteoporosis, are not as well acknowledged in pediatric stem cell transplant survivors. Osteopenia and osteoporosis can lead to fractures, deformities, pain, and financial burden. There are many factors during and after a stem cell transplant that cause patients to be at an increased risk for osteopenia or osteoporosis. Nurses have the ability to prevent these potentially debilitating and progressive diseases and to provide adequate treatment to prevent further complications. Key features of the history, physical examination, and diagnostic imaging can assist with making a diagnosis of osteoporosis or osteopenia. Prevention of osteopenia and osteoporosis involves both lifestyle modifications and medical management. Measures to prevent and treat bone loss are crucial. Transplant nurses must be knowledgeable regarding the risk factors and prevention and treatment strategies for osteopenia and osteoporosis.

Keywords

Key words: osteopenia osteoporosis stem cell transplant pediatric

Get full access to this article

View all access options for this article.

References

Arikoski, P. , Komulainen, J. , Riikonen, P. , Voutilainen, R. , Knip, M. , & Kroger, H. (1999). Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: A 1-year prospective study . Journal of Clinical Endocrinology and Metabolism , 84, 3174-3181 .

Blatt, J. (2004). Keeping your bones healthy after childhood cancer . Retrieved August 18, 2005, from www.childrensoncologygroup.org

Follin, S.L. , & Hansen, L.B. (2003). Current approaches to the prevention and treatment of postmenopausal osteoporosis . American Journal of Health-System Pharmacy, 60, 883-901 .

Food and Nutrition Board. (2003). Dietary reference intakes: Guiding principles for nutrition labeling and fortification . Washington, DC: National Academies Press .

Haddy, T. , Mosher, R. , & Reaman, G. (2001). Osteoporosis in survivors of acute lymphoblastic leukemia . Oncologist, 6, 278-285 .

Ilich, J. , Badenhop, N. , & Matkovic, V. (1996). Primary prevention of osteoporosis: Pediatric approach to disease of the elderly . Women's Health Issues , 6, 194-203 .

Licata, A.A. (2003). An updated look at therapies for osteoporosis . The Clinical Advisor, 6(12), 10-19 .

Prestwood, K.M. , & Raisz, L.G. (2002). Prevention and treatment of osteoporosis . Clinical Cornerstone, 4(6), 31-41 .

Schimmer, A. , Mah, K. , Bordeleau, L. , Cheung, A. , Ali, V. , Falconer, M. , et al. (2001). Post-transplant complications: Decreased bone mineral density is common after autologous blood or marrow transplantation . Bone Marrow Transplantation, 28, 387-391 .

10.

Schimmer, A. , Minden, M. , & Keating, A. (2000). Osteoporosis after blood and marrow transplantation: Clinical aspects . Biology of Blood and Marrow Transplantation , 6, 175-181 .

11.

Schulte, C. , Beelen, D. , Schaefer, U. , & Mann, K. (2000). Bone loss in long-term survivors after transplantation of hematopoietic stem cells: A prospective study . Osteoporosis International, 11, 344-353 .

12.

Steelman, J. , & Zeitler, P. (2001). Osteoporosis in pediatrics . Pediatrics in Review, 22, 56-65 .

13.

Stern, J. , Sullivan, K. , Ott, S. , Seidel, K. , Fink, J. , Longton, G. , et al. (2001). Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study. Biology of Blood and Marrow Transplantation, 7, 257-264 .

14.

Tortora, G. , & Grabowski, S. (1993). Principles of anatomy and physiology. New York: HarperCollins .

15.

Weilbaecher, K. (2000). Mechanisms of osteoporosis after hematopoietic cell transplantation . Biology of Blood and Marrow Transplantation , 6, 165-174 .